Development of an Assay for the COVID-19 Drug Remdesivir- Toward Proper Remdesivir Use in Patients with Pre-Existing Conditions

Application News No. C218 LC-MS Simultaneous Analysis of Remdesivir and Metabolites in Human Plasma  Introduction Table 1 LC and MS Analysis Conditions Remdesivir (brand name: Veklury®), which was developed by Gilead Science (U.S.) for treatment of Ebola virus disease,…

Application News No. C218 LC-MS Simultaneous Analysis of Remdesivir and Metabolites in Human Plasma  Introduction Table 1 LC and MS Analysis Conditions Remdesivir (brand name: Veklury®), which was developed by Gilead Science (U.S.) for treatment of Ebola virus disease,…

Application News No. C217 LC-MS Simultaneous Analysis of Remdesivir and Metabolites in Human plasma Using Fully Automated Sample Preparation LC/MS/MS System  Introduction Remdesivir (brand name: Veklury®), which was developed by Gilead Sciences (U.S.) for treatment of Ebola virus disease,…

Application News No. C217 LC-MS Simultaneous Analysis of Remdesivir and Metabolites in Human plasma Using Fully Automated Sample Preparation LC/MS/MS System  Introduction Remdesivir (brand name: Veklury®), which was developed by Gilead Sciences (U.S.) for treatment of Ebola virus disease,…